Rapid non-viral platform for generation of genetically modified t cells for therapy
Ended Project Grant Awarded Last action
- Award ID
- R44CA233143
- Recipient
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,617,646
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Funding
-
- $1,617,671.79 Federal
- -$25.70 Non-federal
- Place of performance
- Minnesota, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$6,923 | $0 | |
| Amendment | -$26 | $0 | |
| Amendment | -$26 | -$26 | |
| Amendment | -$26 | $0 | |
| Amendment | $314,418 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,091,666 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $218,588 | $0 |
Quick answers
Who received award R44CA233143?
R44CA233143 was awarded to Research And Diagnostic Systems, Inc. by National Cancer Institute (National Institutes of Health) on August 6, 2018.
How much is award R44CA233143 worth?
$1,617,646 has been obligated on R44CA233143: $1,617,672 in federal funding and -$26 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award